Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval save search
Prairie Operating Co. Announces Unanimous Approval of Genesis Oil and Gas Development Plan Adding Multi-Year Inventory of Development Drilling Locations
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
PROP | $15.84 3.87% 3.72% 230K
|
n/a
|
| O: 0.82%
H: 7.26%
C: 2.76%
multi-year approval gas oil
Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
TLRY | News | $1.73 0.58% 0.58% 30M
|
Process Industries
|
| O: 0.0%
H: 0.6%
C: -4.19%
first cannabis approval medical tilray
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Published: 2024-03-14 (Crawled : 11:00) - biospace.com/
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: -0.15%
H: 1.47%
C: 1.4%
AXNX | $67.06 -0.21% -0.21% 510K
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.07%
axonics approval system
Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
MIRM | $23.6 -1.05% -1.06% 400K
|
Health Technology
|
| O: 1.49%
H: 2.98%
C: -0.43%
fda pruritus approval treatment livmarli
Media Alert: IBM Applauds EU Parliament's Approval of the EU AI Act
Published: 2024-03-13 (Crawled : 12:00) - prnewswire.com
IBM | $181.47 -0.89% -0.53% 2.9M
|
Technology Services
|
| O: -0.12%
H: 0.28%
C: -0.43%
media approval
NeuroBo Pharmaceuticals Receives Safety Review Committee Approval to Continue With Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
Published: 2024-03-13 (Crawled : 12:00) - prnewswire.com
NRBO | $3.425 -1.01% -1.02% 23K
|
Health Technology
|
| O: 3.49%
H: 0.2%
C: -11.31%
da-1241 approval review treatment pharmaceuticals trial
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
CMND | $1.2 0.84% 0.83% 35K
|
n/a
|
| O: -2.72%
H: 1.4%
C: -4.9%
approval
Heritage NOLA Bancorp, Inc. Announces Application Status and Shareholder Approval for Proposed Merger With M C Bancshares, Inc.
Published: 2024-03-13 (Crawled : 09:00) - prnewswire.com
HRGG | $14.63 -0.36% 200
|
Finance and Insurance
| Email alert
Add to watchlist
approval application
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
Published: 2024-03-12 (Crawled : 15:00) - globenewswire.com
NCAC | $4.79 3.13% 21K
|
| Email alert
Add to watchlist
nasdaq approval research
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
Published: 2024-03-12 (Crawled : 11:00) - globenewswire.com
BCDA | $0.363 -1.39% -1.4% 62K
|
Health Technology
|
| O: 5.58%
H: 2.85%
C: -14.27%
approval cell cardiamp heart therapy study
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
TVTX | $5.805 -3.09% -3.19% 970K
|
Health Technology
|
| O: -0.81%
H: 1.51%
C: -6.98%
filspari nephropathy drug approval food treatment application therapeutics
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
PLUR | $5.02 -2.9% -2.99% 12K
|
Manufacturing
|
| O: 0.0%
H: 0.99%
C: -4.1%
patent approval cell technology
Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 0.23%
H: 0.9%
C: -0.68%
praluent fda children genetic cholesterol approval treat injection
United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
Published: 2024-03-10 (Crawled : 00:00) - globenewswire.com
MESO | $5.14 2.6% 2.53% 270K
|
Health Technology
|
| O: 16.28%
H: 27.6%
C: 6.4%
drug device approval food heart
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.98%
H: 3.17%
C: 0.9%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
fda brukinsa approval
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa; Opdivo Approved for B...
Published: 2024-03-08 (Crawled : 17:00) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.98%
H: 3.17%
C: 0.9%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
fda opdivo approved approval
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.29%
fda drug approval treatment
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
Published: 2024-03-08 (Crawled : 15:00) - biospace.com/
SENS | $0.416 3.43% 0.7% 2.2M
|
Electronic Technology
|
| O: 1.51%
H: 6.65%
C: 4.18%
eversense conference approval international advanced diabetes study
BeiGene Announces FDA Accelerated Approval of BRUKINSA for the Treatment of Relapsed or Refractory Follicular Lymphoma
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -0.93%
H: 3.2%
C: 2.66%
fda brukinsa approval treatment
Home Federal Bancorp, Inc. of Louisiana Announces Receipt of Regulatory Approval for Dividend from Home Federal Bank and Approval of Stock Repurchase Program
Published: 2024-03-07 (Crawled : 23:00) - globenewswire.com
HFBL | $12.18 1.5% 1.48% 1.9K
|
Finance
|
| O: 3.92%
H: 0.0%
C: -0.0%
approval repurchase program home
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.